Vital Prospects Clinical Research Institute, P.C — Tulsa, Oklahoma

Vital Prospects Clinical Research Institute, P.C is a clinical research site located in Tulsa, Oklahoma, United States 74136.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Vital Prospects Clinical Research Institute, P.C has participated in 30 clinical trials with 4 currently active.

Therapeutic areas: Alopecia Areata, Eosinophilic Esophagitis, Primary Immunodeficiency Diseases (PID).

Sponsors: Pfizer, Ellodi Pharmaceuticals, LP, Baxalta now part of Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tulsa

Browse all research sites in Oklahoma · View every site in Tulsa

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vital Prospects Clinical Research Institute, P.C?

Vital Prospects Clinical Research Institute, P.C has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vital Prospects Clinical Research Institute, P.C conducted?

Vital Prospects Clinical Research Institute, P.C has 30 clinical trials on record, with 4 currently active. Their work covers Alopecia Areata, Eosinophilic Esophagitis, Primary Immunodeficiency Diseases (PID).

Is Vital Prospects Clinical Research Institute, P.C accredited by Crixeo Clinical Trials?

Vital Prospects Clinical Research Institute, P.C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vital Prospects Clinical Research Institute, P.C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.